Sandy Eldridge

502 total citations
14 papers, 256 citations indexed

About

Sandy Eldridge is a scholar working on Molecular Biology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Sandy Eldridge has authored 14 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Sandy Eldridge's work include Pluripotent Stem Cells Research (4 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Neuroscience and Neural Engineering (3 papers). Sandy Eldridge is often cited by papers focused on Pluripotent Stem Cells Research (4 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Neuroscience and Neural Engineering (3 papers). Sandy Eldridge collaborates with scholars based in United States, Japan and Germany. Sandy Eldridge's co-authors include Liang Guo, Mark M. Davis, Michael J. Engwall, Yasunari Kanda, Gary A. Gintant, Brian D. Guth, John Koerner, Holger Behrsing, Brian R. Berridge and Jennifer Pierson and has published in prestigious journals such as Toxicology and Applied Pharmacology, Toxicological Sciences and Frontiers in Pharmacology.

In The Last Decade

Sandy Eldridge

13 papers receiving 252 citations

Peers

Countries citing papers authored by Sandy Eldridge

Since Specialization

Citations

This map shows the geographic impact of Sandy Eldridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandy Eldridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandy Eldridge more than expected).

Fields of papers citing papers by Sandy Eldridge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandy Eldridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandy Eldridge. The network helps show where Sandy Eldridge may publish in the future.

Co-authorship network of co-authors of Sandy Eldridge

This figure shows the co-authorship network connecting the top 25 collaborators of Sandy Eldridge. A scholar is included among the top collaborators of Sandy Eldridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandy Eldridge. Sandy Eldridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Development of a workflow for in vitro on– and off-target cytotoxicity assessment of CAR T cell therapies to support first-in-human clinical trials: An orthogonal approach using human induced pluripotent stem cell-derived cells as a surrogate for normal vital organ systems 2025 ·Current Research in Toxicology ·(unknown), (unknown), (unknown), (unknown), Sandy Eldridge	0
2	Collaborative science in action: A 20 year perspective from the Health and Environmental Sciences Institute (HESI) Cardiac Safety Committee 2024 ·Journal of Pharmacological and Toxicological Methods ·Jennifer Pierson, Brian R. Berridge, Ksenia Blinova, Marjory B. Brooks, Sandy Eldridge, (unknown), Michael K. Pugsley, A. Eric Schultze, Godfrey L. Smith, Norman Stockbridge, Jean‐Pierre Valentin, José Vicente	1
3	Considerations for a Reliable In Vitro Model of Chemotherapy-Induced Peripheral Neuropathy 2021 ·Toxics ·Sandy Eldridge, Arianna Scuteri, Eugenia Jones, Guido Cavaletti, Liang Guo, (unknown)	5
4	Considerations for an In Vitro, Cell-Based Testing Platform for Detection of Adverse Drug-Induced Inotropic Effects in Early Drug Development. Part 1: General Considerations for Development of Novel Testing Platforms 2019 ·Frontiers in Pharmacology ·Brian D. Guth, Michael J. Engwall, Sandy Eldridge, C. Michael Foley, Liang Guo, Gary A. Gintant, John Koerner, Stanley T. Parish, Jennifer Pierson, Alexandre J. S. Ribeiro, Tanja S. Zabka, Khuram W. Chaudhary, Yasunari Kanda, Brian R. Berridge	16
5	Spontaneously occurring cardiovascular lesions in commonly used laboratory animals 2019 ·Cardio-Oncology ·Eugene H. Herman, Sandy Eldridge	8
6	Considerations for an In Vitro, Cell-Based Testing Platform for Detection of Drug-Induced Inotropic Effects in Early Drug Development. Part 2: Designing and Fabricating Microsystems for Assaying Cardiac Contractility With Physiological Relevance Using Human iPSC-Cardiomyocytes 2019 ·Frontiers in Pharmacology ·Alexandre J. S. Ribeiro, Brian D. Guth, Michael J. Engwall, Sandy Eldridge, C. Michael Foley, Liang Guo, Gary A. Gintant, John Koerner, Stanley T. Parish, Jennifer Pierson, Mathew Brock, Khuram W. Chaudhary, Yasunari Kanda, Brian R. Berridge	36
7	A Comparative Review of Chemotherapy-Induced Peripheral Neuropathy in In Vivo and In Vitro Models 2019 ·Toxicologic Pathology ·Sandy Eldridge, Liang Guo, (unknown)	55
8	Role of Mcl-1 in regulation of cell death in human induced pluripotent stem cell-derived cardiomyocytes in vitro 2018 ·Toxicology and Applied Pharmacology ·Liang Guo, Sandy Eldridge, (unknown), (unknown), Mark M. Davis	9
9	Multiparametric Image Analysis of Rat Dorsal Root Ganglion Cultures to Evaluate Peripheral Neuropathy-Inducing Chemotherapeutics 2016 ·Toxicological Sciences ·Liang Guo, (unknown), Sandy Eldridge, Holger Behrsing, (unknown), (unknown), Mark M. Davis	29
10	Toxicogenomics profiling of bone marrow from rats treated with topotecan in combination with oxaliplatin: a mechanistic strategy to inform combination toxicity 2015 ·Frontiers in Genetics ·Mark M. Davis, Jianying Li, (unknown), Sandy Eldridge, (unknown), Pierre R. Bushel	10
11	Use of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes (hiPSC‐CMs) to Monitor Compound Effects on Cardiac Myocyte Signaling Pathways 2015 ·PubMed ·Liang Guo, Sandy Eldridge, (unknown), (unknown), Mark M. Davis	28
12	Characterization of acute biliary hyperplasia in Fisher 344 Rats administered the Indole-3-Carbinol Analog, NSC-743380 2014 ·Toxicology and Applied Pharmacology ·Sandy Eldridge, Joseph M. Covey, Joel Morris, Bingliang Fang, Thomas Horn, (unknown), (unknown), David L. McCormick, Myrtle A. Davis	5
13	Examining the Protective Role of ErbB2 Modulation in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes 2014 ·Toxicological Sciences ·Sandy Eldridge, Liang Guo, (unknown), (unknown), (unknown), Mark M. Davis	35
14	Comparative Uterotrophic Effects of Endoxifen and Tamoxifen in Ovariectomized Sprague-Dawley Rats 2014 ·Toxicologic Pathology ·Karen Schweikart, Sandy Eldridge, Stephanie L. Safgren, Toufan Parman, Joel M. Reid, Matthew M. Ames, Matthew P. Goetz, Myrtle A. Davis	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact